News & Updates

Show Multimedia Only
High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer

High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer

15 Jan 2022

In patients with clinically localized Gleason 9–10 prostate cancer, dose-escalated radiotherapy confers better biochemical disease-free survival and prostate cancer-specific mortality than conventional doses, a recent study has found.

15 Jan 2022